BridgeBio Pharma
BBIO
#1405
Rank
A$22.37 B
Marketcap
A$114.87
Share price
-2.75%
Change (1 day)
8.92%
Change (1 year)

Earnings for BridgeBio Pharma (BBIO)

Earnings in 2026 (TTM): -A$0.54 Billion

According to BridgeBio Pharma 's latest financial reports the company's current earnings are A$0.94 Billion. In 2025 the company made an earning of -A$0.84 Billion a decrease over its 2024 earnings that were of -A$0.67 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BridgeBio Pharma from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.54 Billion-36.49%
2025 -A$0.84 Billion25.14%
2024 -A$0.67 Billion-22.56%
2023 -A$0.87 Billion41.5%
2022 -A$0.62 Billion-25.1%
2021 -A$0.82 Billion15.11%
2020 -A$0.71 Billion67.55%
2019 -A$0.43 Billion67.65%
2018 -A$0.26 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.25 Billion-56.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$27.44 Million-95.00%๐Ÿ‡บ๐Ÿ‡ธ USA